Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 589-592

  Roilides, Emmanuel ^b   Sein, Tin ^b   Schaufele, Robert ^b   Chanock, Stephen J ^b   Walsh, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4;

ARTICLE; BIOPSY; BLOOD LEVEL; CANCER PATIENT; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER; PRIORITY JOURNAL; SPLEEN;

EID: 0031850587     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517481     Document Type: Article

References (14)

1. Walsh TJ, Whitcomb PO, Revankar SG, Pizzo PA. Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer 1995; 76:2357-62.
2. Anttila VJ, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 1997; 24:375-80.
3. Puccetti P, Romani L, Bistoni F. A Th1-Th2-Iike switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995; 3:237-40.
4. Cenci E, Romani L, Mencacci A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur 3 Immunol 1993;23:1034-8.
5. Tonnetti L, Spaccapelo R, Cenci E, et al. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol 1995;25:1559-65.
6. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
7. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996; 174:994-1000.
8. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178:2207-11.
9. Hart PH, Jones CA, Finlay-Jones JJ. Interleukin-4 suppression of monocyte tumour necrosis factor-α production. Dependence on protein synthesis but not on cyclic AMP production. Immunology 1992; 76:560-5.
10. Anastasiou A, Roilides E, Dimitriadou A, Kadiltsoglou I, Panteliadis C, Walsh TJ. Interleukin-10 suppresses antifungal activities of human monocytes against pseudohyphae and blastoconidia of Candida albicans (abstract B54). In: American Society for Microbiology Conference on Candida and Candidiasis: Biology, Pathogenesis, and Management (San Diego). Washington, DC: ASM, 1996.
11. Laichalk LL, Danforth JM, Standiford TJ. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol Med Microbiol 1996; 15:181-7.
12. Marchant A, Deviere J, Byl B, de Groote D, Vincent JL, Goldman M. Interleukin-10 production during septicaemia. Lancet 1994; 343: 707-8.
13. Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 1995; 171:229-32.
14. Romani L, Puccetti P, Mencacci A, et al. Neutralization of IL-10 upregulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994; 152:3514-21.